A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
Clinical trial NCT02359058 · COMPLETED
Trial details
- NCT number
- NCT02359058
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.